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We have investigated the interactions between synthetic amphipathic peptides and zwitterionic model membranes. Peptides with 14 and 21
amino acids composed of leucines and phenylalanines modified by the addition of crown ethers have been synthesized. The 14-mer and 21-mer
peptides both possess a helical amphipathic structure as revealed by circular dichroism. To shed light on their mechanism of membrane interaction,
different complementary biophysical techniques have been used such as circular dichroism, fluorescence, membrane conductivity measurement
and NMR spectroscopy. Results obtained by these different techniques show that the 14-mer peptide is a membrane perturbator that facilitate the
leakage of species such as calcein and Na ions, while the 21-mer peptide acts as an ion channel. 31P solid-state NMR experiments on multilamellar
vesicles reveal that the dynamics and/or orientation of the polar headgroups are greatly affected by the presence of the peptides. Similar results
have also been obtained in mechanically oriented DLPC and DMPC bilayers where different acyl chain lengths seem to play a role in the
interaction. On the other hand, 2H NMR experiments on multilamellar vesicles demonstrate that the acyl chain order is affected differently by the
two peptides. Based on these studies, mechanisms of action are proposed for the 14-mer and 21-mer peptides with zwitterionic membranes.
© 2006 Elsevier B.V. All rights reserved.Keywords: Synthetic amphipathic peptide; Model membrane; NMR spectroscopy; Circular dichroism; Single-channel conductivity; Fluorescence
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In the last few decades, bacterial resistance against
commonly used antibiotics has become an increasingly
important public health problem. Enormous efforts are devoted
to reduce the number of antibiotic resistant bacteria. Scientists
have therefore concentrated their efforts on the elucidation of
bacterial cell functions to identify new bacterial targets, and on
the design and development of new classes of antimicrobial
agents that possess novel modes of action that could overcome
known mechanisms of bacterial resistance [1–5]. The focus of
the present review is on the design and synthesis of novel
potential antimicrobial compounds.
More than 880 different antimicrobial peptides, which are an
important component of the defense system of a variety of
species such as mammals, plants, insects, viruses and bacteria,
have been reported or predicted from nucleic acid sequences
and they became the focus of many researches [5–7]. Despite
the fact that natural antimicrobial peptides do not show primary
structure homology, they possess the following general trends:
they are relatively small, they have a net positive charge of +2 to
+7, they adopt a variety of three dimensional structures such as
α-helix and β-sheet conformations conferring an amphipathic
character, they possess a broad spectrum of activity and they are
recognized to kill bacteria rapidly so they do not contribute to
the rapid emergence of resistance [6,8–12].
Antimicrobial peptides as a source of potential therapeutic
agents have brought the scientific community to shed light on
the structural parameters required for their antimicrobial
activity, in an ultimate goal of elucidating their mechanisms
of action. A better understanding of these mechanisms will
allow the design of novel therapeutic peptides that possess the
required specificity against bacteria and that act via new modes
of action defying most of the known mechanisms of bacterial
resistance [5]. Despite the characteristics listed above, several
natural antimicrobial peptides such as melittin from bee venom
present the disadvantage of being toxic to eukaryotic cells [13].
Many research groups have therefore oriented their work on the
design and synthesis of model antimicrobial peptides with
increased antimicrobial activity and reduced toxicity to
eukaryotic cells. The synthetic peptide approach in a view of
examining variations in structural parameters such as hydro-
phobicity/hydrophilicity balance, amphipathicity, charge and
helicity will enable rapid progress in the design of selective
antimicrobial peptides in an efficient way [14]. These studies
have brought new information on the structural parameters
required for the desired antimicrobial activity, and general
mechanisms of action that follow from such parameters have
been suggested, such as the “carpet-like”, “barrel-stave” and
“toroidal” mechanisms [15–20].
For example, Stark et al. have designed a new category of
nonamphipathic hydrophobic antimicrobial peptides that seem
to selectively permeabilize bacterial cells via the “carpet-like”
mechanism [21]. From their study, they concluded that the
antimicrobial activity coincides with a threshold hydrophobicity
that is required for peptide insertion into bacterial membranes. A
26-residue peptide with varying D- and L-amino acids in theprimary sequence has been studied by Chen et al. to investigate
the effect of peptide hydrophobicity/hydrophilicity balance,
amphipathicity and helicity on biological activity [14]. Synthetic
peptides with ingenious conformation named antimicrobial
dendrimeric peptides, that can be easily chemically modified to
amplify the antimicrobial activity, have been synthesized by
Tam et al. [22]. By varying the size of the dendrimeric peptides,
they have obtained an optimal peptide with four branched lysine
residues that adopts a barrel-like structure with high antimicro-
bial activity without hemolysis. Many research groups have
focused their attention on hybrids of natural antimicrobial
peptides such as, for example, the cecropin-melittin hybrids
[23–26]. By joining specific amino acid sequences from natural
antimicrobial peptides, they have obtained very promising
hybrids with improved antimicrobial activity without hemolytic
properties. Schmitt et al. and Epand et al. have both oriented
their research on the design and structure–function study of
synthetic peptides composed of unnatural β-amino acids called
β-17 peptides and an alternance of α- and β-amino acids called
α,β-peptides [27–29]. Variation in the helical conformation of
these foldamers confers different biological activities that can be
correlated to the amphipathic character of the helical structure.
The membrane permeabilization activity of the peptides listed
above has been tested on model membranes and on the
membranes of both Gram-negative and Gram-positive bacteria.
These studies have revealed that the lipid membrane of
prokaryotic and/or eukaryotic cells seems to be the primary or
final target of such peptides and that their biological activity
appears to be modulated by peptide structural parameters such as
helicity, positive charge, amphipathic character and hydropho-
bicity [30–34].
Another interesting point to be addressed here is the design
of ion channel peptides. Many natural antimicrobial peptides
acting via a channel mechanism and pore-forming helical
peptides are reported in the literature [35]. Ion channel peptides
are promising antimicrobial agents since they could affect the
bacterial membrane electrochemical potential and then kill the
pathogens [36]. Many research groups and in particular
DeGrado et al. have elucidated the structural parameters
required for membrane channel activity and they designed
model ion channel peptides [37–39]. The model developed by
DeGrado is a 21-residue peptide composed of leucine and serine
residues. This peptide was shown to form ion channels and
showed ion permeability and open lifetime properties similar to
the acetylcholine receptor [40–42]. Fernandez-Lopez et al. have
also designed cyclic D,L-α-peptides able to selectively target
and self-assemble in bacterial membranes to exert antibacterial
activity by increasing membrane permeability [43]. For a
detailed list of synthetic model ion channel peptides, the readers
are referred to the paper of Gokel et al. [39].
2. Model amphipathic peptides containing crown ethers
Inspired by the promising future of synthetic antimicrobial
peptides as an alternative to antibiotics, the research group of N.
Voyer has concentrated its efforts on the design and synthesis of
novel model peptides presenting various membrane activities.
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made from leucines and phenylalanines modified with crown
ethers [44]. These amino acids are known to increase the helical
propensity of the chain and crown ethers are ingeniously
positioned to lead to their alignment under a helical conforma-
tion. This organization is useful for two reasons. First, once
incorporated into membranes, the peptide can allow ion
translocation from one crown ether to another and thus create
a channel [45,46]. Second, the polar crown ethers on the same
side and the hydrophobic leucines on the other side result in an
amphipathic peptide that can mimic properties of natural
membrane-active peptides [47]. A 21-mer peptide was first
designed, since it has the required length to fit in biological
membranes and it could therefore act as an ion channel. In
addition, a 14-mer peptide was designed as a lytic peptide that
could more easily disturb membranes because of its shorter
length not matching a membrane thickness. These peptides were
prepared by solid-phase peptide synthesis on oxime resin, a
technique that has been shown to be fast and efficient [48,49].
This strategy allows easy modifications at the N- and C-termini
by peptidic coupling or nucleophilic cleavage to rapidly obtain a
wide variety of analogues [50,51]. Protected and fully
deprotected compounds have been synthesized, and other
peptides bearing more or less polar terminal groups were also
prepared (Fig. 1). Unless indicated otherwise, the peptides
investigated in the present study are the 14-mer peptide with
n=2 and Y_OH (peptide B) and the 21-mer peptide with n=3
and Y_OCH3 (peptide C).
Since the biological membrane seems to be the target of
several natural and synthetic antimicrobial peptides, the
structure and function of the 14-mer and 21-mer peptidesFig. 1. 7-mer, 14-mer and 21-mer peptides with different N-terminal and C-terminal g
are the 14-mer peptide with n=2 and Y_OH (peptide B) and the 21-mer peptide whave been investigated in synthetic model membranes. The
advantage of model lipid bilayers resides in the fact that the
physical state as well as the chemical composition of these
membranes can be easily modified using zwitterionic and/or
anionic lipids to mimic eukaryotic and bacterial membranes.
Lipid vesicles with different sizes can also be prepared. Multi-
lamellar vesicles with typical sizes of the order of a micron were
used for NMR studies [52], while lipid vesicles with sizes
between 175 and 200 nm were prepared via extrusion and
filtration with micro-pore filters for leakage studies [53].
Notably, unlike most known natural and synthetic antimi-
crobial peptides, the 14-mer and 21-mer peptides used in the
present study do not possess a net positive charge. Their neutral
nature allows the study of the effect of hydrophobic forces in the
interaction with lipids without the influence of strong
electrostatic interactions.
3. Conformation of the 14-mer and 21-mer peptides
Circular dichroism (CD) spectropolarimetry was used to
investigate the conformation of the 14-mer and the 21-mer
peptides both in solution and bound to lipid bilayers.
Measurements were performed in trifluoroethanol with a
peptide concentration of 1.0 mg/mL and in egg yolk lecithin
vesicles with a lipid-to-peptide molar ratio of 80:1. In the latter
case, the lipids and peptides were codissolved in chloroform
prior to sample hydration. The specific dichroic signatures of
conformations such as α-helix, β-sheet and random coil are
well documented. For α-helices, two minima at 208 and 222 nm
are expected, for β-sheets structure a minimum at 215 nm is
observed, while the random coil conformation gives a minimumroups. Unless indicated otherwise, the peptides investigated in the present study
ith n=3 and Y_OCH3 (peptide C).
Fig. 2. CD spectra of the 14-mer and the 21-mer peptides in solution (TFE) at a
concentration of 0.1 M, and bound to egg lecithin vesicles at a lipid-to-peptide
molar ratio of 80:1. Adapted from reference [46] and reproduced with
permissions.
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spectra of the 14-mer and the 21-mer peptides both in TFE and
in lipid vesicles. All CD spectra revealed that the 14-mer and
21-mer peptides exhibit an α-helical conformation in both
media. An interesting point to note here is the partial dis-
appearance of the component at 209 nm on the CD spectrum of
the 21-mer peptide in vesicles (Fig. 2). It has already been
reported that the extent of this disappearance varies with the cell
path length at constant concentration. A similar CD behavior
has already been reported in the literature for α-helical peptides
incorporated in lipid bilayers. This phenomenon has been
suggested to be associated with the orientation of the helical
peptides in the lipid bilayer on the quartz surface [54]. CD
studies at different concentrations (0.1 μM–0.1 mM) also point
out that the 21-mer peptide and its analogues do not tend to
aggregate in low polarity environment as suggested by the
conservation of the ellipticity at 222 nm [46].
4. Transport and lytic activity of the 14-mer and 21-mer
peptides
To investigate the transport and lytic properties of the crown
peptides, different complementary techniques have been used
such as pH-stat, monomolecular membrane conductivity, 23Na
NMR and calcein fluorescence spectroscopies.
4.1. pH-stat
The pH-stat technique is based on the pH difference between
the internal and external environment of unilamellar lipid
vesicles [55]. Essentially, vesicles made with an internal pH of
6.6 are placed in an external solution of pH 7.6. Then specific
ions and FCCP (carbonyl cyanide 4-(trifluoromethoxy)phenyl-
hydrazone) [56], a proton carrier, are added and transport ability
can be monitored by the release of protons required to maintainthe electroneutrality across the vesicle membranes [57]. Results
obtained in PC/PA/cholesterol vesicles with the 21-mer peptide
indicate a similar Cs+ transport activity as gramicidin A, a
peptide known to form very efficient ion channels [44].
Moreover, the 21-mer peptide showed comparable activities
with Li+, Na+, K+ and Rb+, while analogues without crown
ethers and the monomer of a crown ether phenylalanine showed
only very weak transport typical of a carrier mechanism. These
results suggest that the 21-mer peptide affects ion transport via a
channel mechanism and that ions most probably pass through
the crown ether stack instead of through a pore formed by self-
assembled peptides. On the other hand, the addition of Triton X-
100 at the end of every experiment led to the complete lysis of
the vesicles and the release of entrapped H+, which demon-
strates that the vesicles are still intact at the end of the assay and
that the 21-mer peptide does not act as a surfactant.
4.2. Monomolecular membrane conductivity
To further characterize the transport ability of the 21-mer
peptide, single-channel measurements [58,59] have been
performed using a modified patch clamp technique [60]. This
technique is based on the measurement of the electric current
resulting of ions passing through a diphytanoylglycerolpho-
sphocholine (DiPhy) bilayer adsorbed on a pipette tip. Results
with the 21-mer peptide in the presence of K+ show typical
transitions (steps) between “closed” and “open” states, that are
characteristic of ion channel activity observed with natural
channel proteins [45,46]. In DiPhy membranes, the 21-mer
peptide has a current level of 2.5±0.2 pA with an average
lifetime for the open states of about 1 s. Furthermore,
experiments with the 21-mer peptide bearing smaller 18-
crown-6 moieties showed a conductivity of 3.5±0.2 pA and
average lifetime of opening of 100-200 ms, differing greatly
from results obtained with 21-crown-7 channel and supporting
that ions travel across the crown ether stack (J.-C. Meillon, N.
Voyer, unpublished results). These results agree with the
conclusions from the pH-stat studies and strongly support a
channel mechanism.
4.3. 23Na NMR
In order to further validate the channel activity of the 21-mer
peptide and to screen more analogues, a dynamic NMR method
has been used. This method allows a good evaluation of sodium
channel transport activity without any driving force. Based on
the differentiation of Na+ inside and outside phospholipid
vesicles by the use of Dy3+ as shift reagent, this technique
provides an exchange rate of Na+ ions through model mem-
branes and has been successfully applied to gramicidin and
artificial ion channels [53,61,62]. Studies have demonstrated
that the transport activity of the 21-mer peptide, even if it
corresponds to 3% of that of gramicidin D, is 30 times higher
than that of an analogue bearing smaller rings (18-crown-6) and
more than 600 times higher than that of peptides with even
smaller rings (14-crown-4 and 13-crown-3) [48]. This strongly
supports the monomolecular channel mechanism of the 21-mer
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crown ring channel instead of through a pore formed by the
aggregation of peptides, which is in agreement with CD and
patch clamp studies. Furthermore, addition of a non-ionic
hydrophilic head group at the N-terminal of the 21-mer peptide
(peptide D) resulted in an increase by 2.7 times of the Na+
transport activity, while the transport is only slightly improved
for C-polar terminal 21-mer peptide (peptide E) and N,C-polar
termini 21-mer peptide (peptide F) [63].
These results suggest that the addition of a polar group at the
N-terminal position increases the stability of the peptide in the
membrane without decreasing its incorporation. Furthermore, it
demonstrates that the transport activity can be enhanced with
different peptide extremities and opens the way to the
incorporation of molecular recognition elements for selective
targeting. Finally, the results obtained with the 14-mer peptide
indicate a similar transport activity than for the 21-mer peptide,
even if the length of the peptide is shorter than the thickness of
the bilayer. This is most likely due to the fact that the lysis of
vesicles produces the same signal as transport. It is therefore
very difficult to discriminate the two phenomena by this NMR
technique.
4.4. Fluorescence studies
Fluorescence assays have also been performed to verify that
the activity observed by 23Na NMR for the 21-mer peptide is
not due to the lysis of vesicles and to demonstrate the lytic
ability of the 14-mer peptide. The vesicle lysis experiment is
based on the increase of the self-quenched fluorescence of
calcein upon lysis [47,64]. Fig. 3 shows the calcein release
profile induced by the addition of the 14-mer and the 21-mer
peptides to lipid vesicles. These results indicate that the 21-mer
peptide induces very little lysis, which is also the case for the N-
polar terminal 21-mer peptide (peptide D), C-polar terminal 21-
mer peptide (peptide E) and N,C-polar termini 21-mer peptide
(peptide F) bearing one or two polar headgroups (data not
shown) [48,63]. These results confirm that the activity observedFig. 3. Calcein leakage induced by the addition of the 14-mer and the 21-mer
peptides (5 mM) to phosphatidylglycerol/phosphatidylcholine (1:1) vesicles in
HEPES 100 mM, NaCl 170 mM, EDTA 5 mM at pH 7.4. Vesicles were lysed
with Triton X-100 at 400 s. Adapted from reference [47] and reproduced with
permissions.in the 23Na NMR assay reflects the transport ability of the 21-
mer artificial channel. On the other hand, the 14-mer peptide
clearly induces a rapid and significant release of calcein. This
particularity demonstrates the ability of the 14-mer peptide to
act as a lytic agent as predicted.
5. Effects of the 14-mer and 21-mer peptides on model
membranes
This section will be devoted to the study of the effect of the
14-mer and 21-mer peptides on lipid bilayers by a combination
of 31P and 2H solid-state NMR spectroscopy. These two
techniques allow the study of both the polar and the
hydrophobic regions of the lipid bilayer. Both peptides have
been investigated with fully hydrated zwitterionic multilamellar
vesicles composed of dimyristoylphosphatidylcholine (DMPC)
at lipid-to-peptide molar ratios of 60:1 and 20:1, and with fully
hydrated mechanically oriented bilayers of dilauroylphosphati-
dylcholine (DLPC) and DMPC at a lipid-to-peptide molar ratio
of 60:1.
5.1. 31P NMR spectroscopy
Phosphorus-31 has a spin-1/2 and a 100% natural abun-
dance, and, due to its good sensitivity, is extremely useful to
investigate the structure and dynamics of the polar headgroup of
phospholipids, which are the main constituent of biological
membranes [65]. In particular, it is possible to obtain static 31P
NMR spectra which are dominated by the chemical shift
anisotropy (CSA), to use the magic-angle spinning (MAS)
technique that averages the CSA to its isotropic value, and
finally to use samples macroscopically oriented in the magnetic
field. The general conclusions that will be presented in this
section for the 14-mer and 21-mer peptides in interaction with
lipids refer to the shape of the vesicles, the dynamics and/or
orientation of the polar headgroup upon peptide binding to
unoriented vesicles, and also on the perturbing effect of the
peptides on membrane orientation and the influence of acyl
chain length on the interaction between peptides and mechan-
ically aligned bilayers of DLPC and DMPC.
The 31P NMR spectra of the DMPC vesicles revealed that
the 14-mer and the 21-mer peptides increase the dynamics and/
or induce changes in the polar headgroup orientation since a
decrease of the CSA has been observed. The shape of the
DMPC vesicles in the presence of the 14-mer and the 21-mer
peptides also demonstrate a greater 0° orientation of the lipidic
molecules, i.e., with the lipid long axis preferentially oriented
parallel to the magnetic field direction upon peptide binding. A
partial 90° orientation is observed for the pure system, i.e., an
ellipsoidal vesicular shape in which the lipid long axis is
oriented preferentially perpendicular to the magnetic field
direction [66,67]. The greater 0° orientation is reflected on the
31P NMR spectra by an increase of the spectrum shoulder at
approximately 30 ppm. The change in the DMPC vesicular
shape could be explained by a change in the elastic properties of
the vesicles or by a modification of the magnetic susceptibility
of the lipid molecules upon peptide binding [68–70].
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the dynamics and/or orientation of the lipid polar headgroup.
Such perturbation could be explained by the amphipathic nature
of the peptides. When adsorbed at the bilayer surface, the crown
ethers are facing the aqueous phase while the hydrophobic
contour of the helix is facing the hydrophobic core of the
bilayer. This interfacial interaction could result in a change in
the dynamics and/or orientation of the polar headgroup. Similar
results have been reported by Bonev et al. who have studied the
interaction between DMPC and sphingomyelin (10% mol)
membranes and equinatoxin II [71]. Huster et al. have also
studied the colicin Ia channel in interaction with POPC/POPG
vesicles and they concluded that colicin Ia interacts with the
lipid bilayer since a smaller 31P CSA has been observed [72].
Several other groups have also performed 31P NMR experi-
ments on antimicrobial and human peptides [73–76]. They all
attributed a decrease in the CSA to a perturbation of the lipid
headgroup packing.
We have also used 31P NMR to investigate the interaction
between the 14-mer and 21-mer peptides with lipid bilayers
oriented between glass plates [77–79] prior to the determination
of their membrane topology by 15N NMR spectroscopy. Two
different types of lipids have been used, namely DLPC and
DMPC that possess acyl chains of 12 and 14 carbon atoms,
respectively. The choice of lipids has been made by considering
the hydrophobic match/mismatch between the bilayers and
peptides. Assuming that the 14-mer and 21-mer peptides adopt
a perfect α-helical structure, their length would be 21.0 Å and
31.5 Å, while the hydrophobic thickness of DLPC and DMPC is
estimated at 20.0 Å and 23.0 Å, respectively [80,81]. The 31P
NMR oriented spectra of pure DLPC and DMPC bilayers (Fig.
4, solid lines) show sharp resonances at 31.2 ppm and 30.7 ppm,
characteristics of lipid bilayers oriented with their normal
parallel to the magnetic field direction.
In DLPC bilayers, the 14-mer peptide (Fig. 4A, top trace)
induces a broadening of 0.4 ppm and a shift to lower chemical
shift (upfield shift) of 2.0 ppm, while the 21-mer peptide (Fig.
4A, bottom trace) induces a narrowing of the resonance by
0.5 ppm and an upfield shift of 1.0 ppm. In DMPC bilayers,
there is a narrowing (broadening) of the resonance by 0.2Fig. 4. Oriented 31P solid-state NMR spectra of: (A) DLPC bilayers containing th
containing the 14-mer (top trace) and 21-mer (bottom trace) peptides, at a lipid-to-p(0.2 ppm) with the 14-mer (21-mer) peptide (Fig. 4B, top trace
(bottom trace)). Since opposite effects are observed for the 14-
mer and 21-mer peptides in DLPC and DMPC, and that the
length of the 14-mer peptide fits the hydrophobic length of
DLPC bilayers while the length of the 21-mer peptide better fits
the hydrophobic length of DMPC bilayers, we can suppose that
the hydrophobic match/mismatch affects the peptide/lipid
interactions. Based on these results, we can expect a trans-
membrane (in-plane) orientation of the 14-mer peptide in DLPC
(DMPC) bilayers, while the 21-mer peptide is most susceptible
to be oriented in an in-plane (transmembrane) orientation in
DLPC (DMPC) bilayers.
We cannot however rule out the possibility that the 21-mer
peptide could be tilted in DLPC bilayers to compensate for
hydrophobic mismatch instead of having an in-plane orienta-
tion. A similar case has already been reported by Park et al. who
have studied the variation in the tilt angle of the transmembrane
helix of Vpu peptide depending on the bilayer thickness [82].
They reported that the tilt angle is changed from 27° in 14:0-O-
PC/PG to 51° in 10:0 PC/10:0 PG lipid bilayers.
5.2. 2H NMR spectroscopy
2H NMR spectroscopy is a very powerful technique to study
the membrane hydrophobic core by replacing the acyl chain
protons by deuterons. Deuterium is a spin-1 nucleus with a
quadrupole moment that interacts with the electric field gradient
at the nucleus, giving rise to the quadrupolar interaction. Two
spin transitions are possible and a doublet of resonances is
observed on a 2H NMR spectrum, separated by the quadrupolar
splitting ΔνQ. For a system with axially symmetric motions, the
quadrupolar splitting is given by:
DmQ ¼ ð3=4Þðe2qQ=hÞð3cos2h 1ÞSCD ð1Þ
where (e2qQ/h) is the quadrupole coupling constant (∼170 kHz
for aliphatic C–D) [83], θ is the angle between the bilayer
normal and the external magnetic field B0, and SCD is the order
parameter of a deuterium bond vector. As described extensively,
this order parameter is the product of several contributions,e 14-mer (top trace) and 21-mer (bottom trace) peptides (B) DMPC bilayers
eptide molar ratio of 60:1 and at 37 °C.
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izations, and anisotropic reorientation of the whole phospho-
lipid molecules. Therefore, it is possible to determine variations
in lipid chain order by monitoring changes in ΔνQ values [84].
The 2H NMR spectra of the DMPC vesicles in the presence
of the 14-mer peptide show an increase in the quadrupolar
splitting ΔνQ at the plateau region while there is no change in
ΔνQ upon the 21-mer peptide binding [66]. The increase inΔνQ
reflects the stabilization on the lipid acyl chains in the presence
of the 14-mer peptide. These results suggest that the peptide is
located at the surface of the bilayer. Dufourc et al. have
observed a similar behavior with melittin [85,86]. They
associated their results to a location of melittin at the surface
of the bilayer, capping the lipid headgroups and leading to a
greater chain packing. A deeper insertion of melittin in the
bilayer results in a disordering effect of the hydrophobic core.
This situation could be explained by the presence of a
hydrophobic mismatch between melittin and the lipid bilayer.
In our case, however, no change is observed in the packing of
the DMPC acyl chains in the presence of the 21-mer peptide.
This could be explained by the fact that the 21-mer peptide and
the DMPC bilayers do not present a significant hydrophobic
mismatch, which would support a transmembrane orientation of
the 21-mer peptide in the bilayer. However, a location of the
peptide at the bilayer surface with no direct effect on the acyl
chain ordering is also conceivable. De Planque et al. concluded
that a hydrophobic match between the bilayer and the peptide
gramicidin A results in a non-perturbed bilayer since no
adjustment has to be done to compensate for hydrophobic
mismatch [81,87]. Belohorcova et al. also reported that a
membrane spanning peptide has little effect on lipid chain order
if its hydrophobic length closely matches the lipid hydrophobic
thickness [88]. Hence, the 14-mer peptide seems to be located at
the surface of the bilayer, while the topology of the 21-mer
peptide has not yet been precisely determined. Further
experiments such as 15N NMR experiments in oriented bilayers
are currently underway with both peptides to conclude on their
membrane topologies.
6. Proposed mechanisms of action
The aim of the present work was to shed light on the
interactions between synthetic amphipathic peptides and model
membranes to better understand the mechanisms of action of
antimicrobial peptides. First, circular dichroism has been used toFig. 5. Proposed models for the binding of the 14-mer (left) and 21-mer (right) peptide
interaction and are not drawn on scale. The 14-mer peptide is inserted in the hydro
hydrophobic side chains interdigitating the hydrocarbon lipid chains. In DMPC bila
orientations that are consistent with previous single-channel conductivity and ATRconfirm the helical conformation of the 14-mer and 21-mer
peptides both in solution and bound to lipid bilayers. Under such
a helical conformation, crown ethers are sequestered on one side
of the α-helix and confer an amphipathic character to the
peptides. Secondly, pH-stat and single-channel measurements,
and 23NaNMRspectroscopy have shown that the 21-mer peptide
acts as an artificial ion channel by promoting the transport of ions
across the lipid bilayer. In addition, calcein leakage experiments
by fluorescence spectroscopy, 23NaNMR spectroscopy and lysis
of erythrocytes [47] by visible spectroscopy have all confirmed
the permeabilization activity of the 14-mer peptide and the non-
lytic activity of the 21-mer peptide. Since ion transport studies
indicated that both peptides interact in a different manner with
lipid membranes, 31P and 2H solid-state NMR studies have been
done on multilamellar vesicles and oriented membranes to gain
information on the interaction of the peptides with lipid bilayers.
These NMR experiments have allowed us to probe the effects of
the 14-mer and 21-mer peptides at two different regions of the
bilayer, namely the polar headgroup and the hydrophobic core.
All these experiments have permitted us to suggest models of
interaction as depicted in Fig. 5.
The results strongly suggest that the 14-mer peptide is located
at the surface of the DMPC bilayer in an in-plane orientation that
minimizes the hydrophobic mismatch between the peptide and
the bilayer and it interacts with the polar headgroup of the lipids.
The perturbing effect of the polar headgroup reflected on the 31P
NMR spectra as well as its perturbing effect on the membrane
permeabilization could be explained by its inverse-cone shape.
According to Epand et al., this peptide belongs to the structural
class A in which the region occupied by the hydrophilic part on
the amphipathic helix is larger than the hydrophobic region, and
this shape is recognized to induce positive curvature in the
bilayer [33]. Such effect has also been reported by Ramamoorthy
et al. who have studied the disruption of the lipid bilayer induced
by an analogue of magainin, MSI-78 [89]. The induction of a
positive curvature by the 14-mer peptide is also supported by a
net decrease of calcein leakage of vesicles made of PC and PE
lipids [47]. The PE lipids possess a cone shape that counter-
balances the inverse-cone shape of the 14-mer peptide, and then
inhibits the positive curvature imposed on the lipid bilayer.
Single-channel measurements and 23Na and solid-state NMR
experiments both suggest a partial transmembrane orientation of
the 21-mer peptide in a DMPC lipid bilayer. Since there is no
significant hydrophobic mismatch between the peptide and the
DMPC bilayer, a transmembrane topology of the 21-mer peptides to DMPC bilayers. Those cartoons represent a static caption of the lipid/peptide
phobic core of the bilayer and adopts an in-plane orientation with the leucine
yers, the 21-mer peptide is in equilibrium between in-plane and transmembrane
studies (see text for details).
1242 M. Ouellet et al. / Biochimica et Biophysica Acta 1758 (2006) 1235–1244could account for its single-channel activity. Previous ATR
studies have also suggested that the 21-mer peptide could be in
equilibrium between in-plane and transmembrane orientations
[54], as depicted in Fig. 5.
7. Conclusions
The present study has demonstrated the utility of the design
and synthesis of artificial amphipathic peptides to better
understand the mechanisms of action of antimicrobial peptides.
A better knowledge of the interactions that support these
modes of action opens the way to novel classes of antibiotics
with different biological activities that defy most known
mechanisms of resistance. The study has also shown the
potential of various biophysical and spectroscopic techniques
to bring complementary information that can be used to shed
light on the mechanisms of action of synthetic amphipathic
peptides.
Acknowledgements
The authors wish to thank Pierre Audet and Jean-Daniel
Doucet for their technical assistance and helpful discussions.
This work was supported by the Natural Science and
Engineering Research Council (NSERC) of Canada, by the
Fonds Québécois de la Recherche sur la Nature et les
Technologies (FQRNT), by the Centre de Recherche sur la
Structure, Fonction et Ingénierie des Protéines (CREFSIP) and
by the Centre de Recherche en Sciences et Ingénierie des
Macromolécules (CERSIM). M.O. also wishes to thank NSERC
for the award of a postgraduate scholarship.
References
[1] D.I. Andersson, Persistence of antibiotic resistant bacteria, Curr. Opin.
Microbiol. 6 (2003) 452–456.
[2] T.E. Cloete, Resistance mechanisms of bacteria to antimicrobial
compounds, Int. Biodeterior. Biodegrad. 51 (2003) 277–282.
[3] R. Krasovec, I. Jerman, Bacterial multicellularity as a possible source of
antibiotic resistance, Med. Hypotheses 60 (2003) 484–488.
[4] D.M. Livermore, Bacterial resistance: origins, epidemiology, and impact,
Clin. Infect. Dis. 36 (2003) S11–S23.
[5] F.R. Schmidt, The challenge of multidrug resistance: actual strategies in
the development of novel antibacterials, Appl. Microbiol. Biotechnol. 63
(2004) 335–343.
[6] R.E.W. Hancock, D.S. Chapple, Peptide antibiotics, Antimicrob. Agents
Chemother. 43 (1999) 1317–1323.
[7] K.A. Brogden, Antimicrobial peptides: pore formers or metabolic
inhibitors in bacteria? Nature 3 (2005) 238–250.
[8] R.M. Epand, H.J. Vogel, Diversity of antimicrobial peptides and their
mechanisms of action, Biochim. Biophys. Acta 1462 (1999) 11–28.
[9] R.E.W. Hancock, Host defence (cationic) peptides, Drugs 57 (1999)
469–473.
[10] R.E.W. Hancock, R. Lehrer, Cationic peptides: a new source of antibiotics,
Trends Biotechnol. 16 (1998) 82–88.
[11] R.E.W. Hancock, Peptide antibiotics, Lancet 349 (1997) 418–422.
[12] P.M. Hwang, H.J. Vogel, Structure–function relationships of antimicrobial
peptides, Biochem. Cell Biol. 76 (1998) 235–246.
[13] N. Sitaram, R. Nagaraj, Interaction of antimicrobial peptides with
biological and model membranes: structural and charge requirements for
activity, Biochim. Biophys. Acta 1462 (1999) 29–54.[14] Y. Chen, C.T. Mant, S.W. Farmers, R.E.W. Hancock, M.L. Vasil, R.S.
Hodges, Rational design of α-helical antimicrobial peptides with enhanced
activities and specificity/therapeutic index, J. Biol. Chem. 280 (2005)
12316–12329.
[15] B. Bechinger, The structure, dynamics and orientation of antimicrobial
peptides in membranes by multidimentional solid-state NMR spectrosco-
py, Biochim. Biophys. Acta 1462 (1999) 157–183.
[16] D. Andreu, L. Rivas, Animal antimicrobial peptides: an overview,
Biopolymers 47 (1998) 415–433.
[17] Z. Oren, Y. Shai, Mode of action of linear amphipathic α-helical
antimicrobial peptides, Biopolymers 47 (1998) 451–463.
[18] Y. Shai, Mechanism of the binding insertion and destabilization of
phospholipid bilayer membranes by α-helical antimicrobial and cell non-
selective membrane-lytic peptides, Biochim. Biophys. Acta 1462 (1999)
55–70.
[19] Y. Shai, Mode of action of membrane active antimicrobial peptides,
Biopolymers 66 (2002) 236–248.
[20] M.R. Yeaman, N.Y. Yount, Mechanisms of antimicrobial peptide action
and resistance, Pharmacol. Rev. 55 (2003) 27–55.
[21] M. Stark, L.-P. Liu, C.M. Deber, Cationic hydrophobic peptides
with antimicrobial activity, Antimicrob. Agents Chemother. 46 (2002)
3585–3590.
[22] J.P. Tam, Y.-A. Lu, J.-L. Yang, Antimicrobial dendrimeric peptides, Eur. J.
Biochem. 269 (2002) 923–932.
[23] H.G. Boman, D. Wade, I.A. Boman, B. Wahlin, R.B. Merrifield,
Antibacterial and antimalarial properties of peptides that are cecropin-
melittin hybrids, FEBS Lett. 259 (1989) 103–106.
[24] H.K. Kim, D.G. Lee, Y. Park, H.N. Kim, B.H. Choi, C.-H. Choi, K.-S.
Hahm, Antibacterial activities of peptides designed as hybrids of
antimicrobial peptides, Biotechnol. Lett. 24 (2002) 347–353.
[25] S.Y. Shin, J.H. Kang, M.K. Lee, K.-S. Hahm, Antibacterial activities of
peptides designed as hybrids of antimicrobial peptides, J. Biochem. Mol.
Biol. 29 (1996) 545–548.
[26] L. Zhang, A. Rozek, R.E.W. Hancock, Interaction of cationic antimicro-
bial peptides with model membranes, J. Biol. Chem. 276 (2001)
35714–35722.
[27] R.F. Epand, N. Umezawa, E.A. Porter, S.H. Gellman, R.M. Epand,
Interactions of the antimicrobial β-peptide β-17 with phospholipid
vesicles differ from membrane interactions of magainins, Eur. J. Biochem.
270 (2003) 1240–1248.
[28] R.F. Epand, M.A. Schmitt, S.H. Gellman, A. Sen, M. Auger, D.W.
Hughes, R.M. Epand, Bacterial species selective toxicity of two isomeric
alpha/beta peptides: role of membrane lipids, Mol. Membr. Biol. 22
(2005) 457–469.
[29] M.A. Schmitt, B. Weisblum, S.H. Gellman, Unexpected relationship
between structure and function in α,β-peptides: antimicrobial folda-
mers with heterogeneous backbones, J. Am. Chem. Soc. 126 (2004)
6848–6849.
[30] M. Dathe, M. Schumann, T. Wieprecht, A. Winkler, M. Beyermann, E.
Krause, K. Matsuzaki, O. Murase, M. Bienert, Peptide helicity and
membrane surface charge modulate the balance of electrostatic and
hydrophobic interactions with lipid bilayers and biological membranes,
Biochemistry 35 (1996) 12612–12622.
[31] M. Dathe, J. Meyer, M. Beyermann, B. Maul, C. Hoischen, M. Bienert,
General aspects of peptide selectivity towards lipid bilayers and cell
membranes studied by variation of the structural parameters of amphi-
pathic helical model peptides, Biochim. Biophys. Acta 1558 (2002)
171–186.
[32] M. Dathe, T. Wieprecht, Structural features of helical antimicrobial
peptides: their potential to modulate activity on model membranes and
biological cells, Biochim. Biophys. Acta 1462 (1999) 71–87.
[33] R.M. Epand, Y. Shai, J.P. Segrest, G.M. Anantharamaiah, Mechanisms for
the modulation of membrane bilayer properties by amphipathic helical
peptides, Biopolymers 37 (1995) 319–338.
[34] T. Kiyota, S. Lee, G. Sugihara, Design and synthesis of amphiphilic α-
helical model peptides with systematically varied hydrophobic–hydro-
philic balance and their interaction with lipid- and bio-membranes,
Biochemistry 35 (1996) 13196–13204.
1243M. Ouellet et al. / Biochimica et Biophysica Acta 1758 (2006) 1235–1244[35] H. Duclohier, How do channel- and pore-forming helical peptides interact
with lipid membranes and how does this account for their antimicrobial
activity? Mini Rev. Med. Chem. 2 (2002) 331–342.
[36] B. Bechinger, Structure and functions of channel-forming peptides:
magainins, cecropins, melittin and alamethicin, J. Membr. Biol. 156
(1997) 197–211.
[37] G.G. Cross, T.M. Fyles, T.D. James, M. Zojaji, Design and synthesis of
artificial ion channels, Synlett (1996) 449–460.
[38] G.W. Gokel, O. Murillo, Synthetic organic chemical models for
transmembrane channels, Acc. Chem. Res. 29 (1996) 425–432.
[39] Q.W. Gokel, A. Mukhopadhyay, Synthetic models of cation-conducting
channels, Chem. Soc. Rev. 30 (2001) 274–286.
[40] K.S. Akerfeldt, J.D. Lear, Z.R. Wasserman, L.A. Chung, W.F. DeGrado,
Synthetic peptides as models for ion channel protein, Acc. Chem. Res. 26
(1993) 191–197.
[41] J.D. Lear, J.P. Schneider, P.K. Kienker, W.F. DeGrado, Electrostatic effects
on ion selectivity and rectification in designed ion channel peptides, J. Am.
Chem. Soc. 119 (1997) 3212–3217.
[42] J.D. Lear, Z.R. Wasserman, W.F. DeGrado, Synthetic amphiphilic peptide
models for protein ion channels, Science 240 (1988) 1177–1181.
[43] S. Fernandez-Lopez, H.-S. Kim, E.C. Choi, M. Delgado, J.R. Granja, A.
Khasanov, K. Kraehenbuehl, G. Long, D.A. Weinberger, K.M. Wilcoxen,
M.R. Ghadiri, Antibacterial agents based on the cyclic D-L-α-peptide
architecture, Nature 412 (2001) 452–455.
[44] N. Voyer, M. Robitaille, A novel functional artificial ion channel, J. Am.
Chem. Soc. 117 (1995) 6599–6600.
[45] N. Voyer, L. Potvin, E. Rousseau, Electrical activity of artificial ion
channels incorporated into planar lipid bilayers, J. Chem. Soc., Perkin
Trans. 2 (1997) 1469–1471.
[46] J.-C. Meillon, N. Voyer, A synthetic transmembrane channel active in lipid
bilayers, Angew. Chem., Int. Ed. 36 (1997) 967–969.
[47] Y.R. Vandenburg, B.D. Smith, E. Biron, N. Voyer, Membrane disruption
ability of facially amphiphilic helical peptides, Chem. Commun. 16 (2002)
1694–1695.
[48] E. Biron, F. Otis, J.-C. Meillon, M. Robitaille, J. Lamothe, P. Van Hove,
M.-E. Cormier, N. Voyer, Design, synthesis, and characterization of
peptide nanostructures having ion channel activity, Bioorg. Med. Chem. 12
(2004) 1279–1290.
[49] N. Voyer, J. Roby, Design, synthesis, and side-chain binding
cooperativity of bis-crown ether peptides, Tetrahedron Lett. 32 (1991)
331–334.
[50] N. Voyer, A. Lavoie, M. Pinette, J. Bernier, A convenient solid-phase
preparation of peptide substituted amides, Tetrahedron Lett. 35 (1994)
355–358.
[51] A. Pichette, N. Voyer, R. Larouche, J.C. Meillon, A useful method for the
preparation of fully protected peptide acids and esters, Tetrahedron Lett. 38
(1997) 1279–1282.
[52] M. Traikia, D.E. Warschawski, M. Recouvreur, J. Cartaud, P.F. Devaux,
Formation of unilamellar vesicles by repetitive freeze–thaw cycles:
characterization by electron microscopy and 31P-nuclear magnetic
resonance, Eur. Biophys. J. 29 (2000) 184–195.
[53] E. Abel, G.E.M. Maguire, O. Murillo, I. Suzuki, S.L. De Wall, G.W.
Gokel, Hydraphile channels: structural and fluorescent probes of position
and function in a phospholipid bilayer, J. Am. Chem. Soc. 121 (1999)
9043–9052.
[54] E. Biron, N. Voyer, J.C. Meillon, M.E. Cormier, M. Auger, Conforma-
tional and orientation studies of artificial ion channels incorporated into
lipid bilayers, Biopolymers 55 (2000) 364–372.
[55] T.M. Fyles, T.D. James, K.C. Kaye, Biomimetic ion-transport-on the
mechanism of ion-transport by an artificial ion channel mimic, Can. J.
Chem. 68 (1990) 976–978.
[56] M. Herve, B. Cybulska, C.M. Garybobo, Cation permeability induced
by valinomycin, gramicidin-D and amphotericin-B in large lipidic
unilamellar vesicles studied by 31P NMR, Eur. Biophys. J. 12 (1985)
121–128.
[57] T.M. Fyles, T.D. James, K.C. Kaye, Activities and modes of action
of artificial ion channel mimics, J. Am. Chem. Soc. 115 (1993)
12315–12321.[58] P. Lauger, Mechanisms of biological ion-transport-carriers, channels, and
pumps in artificial lipid-membranes, Angew. Chem., Int. Ed. 24 (1985)
905–923.
[59] B.A. Suarez-Isla, K. Wan, J. Lindstrom, M. Montal, Single-channel
recordings from purified acetylcholine receptors reconstituted in bilayers
formed at the tip of patch pipets, Biochemistry 22 (1983) 2319–2323.
[60] G.A. Woolley, A.S.I. Jaikaran, Z.H. Zhang, S.Y. Peng, Design of regulated
ion channels using measurements of cis–trans isomerization in single
molecules, J. Am. Chem. Soc. 117 (1995) 4448–4454.
[61] D.C. Buster, J.F. Hinton, F.S. Millett, D.C. Shungu, 23Na-nuclear magnetic
resonance investigation of gramicidin-induced ion transport through
membranes under equilibrium conditions, Biophys. J. 53 (1988) 145–152.
[62] F.G. Riddell, M.K. Hayer, The monensin-mediated transport of sodium
ions through phospholipid bilayers studied by 23Na-NMR spectroscopy,
Biochim. Biophys. Acta 817 (1985) 313–317.
[63] F. Otis, N. Voyer, A. Polidori, B. Pucci, End group engineering of artificial
ion channels, New J. Chem. 2 (2006) 185–190.
[64] T. Benachir, M. Lafleur, Osmotic and pH transmembrane gradients control
the lytic power of melittin, Biophys. J. 70 (1996) 831–840.
[65] J. Seelig, 31P nuclear magnetic resonance and the head group structure of
phospholipids in membranes, Biochim. Biophys. Acta 515 (1978)
105–140.
[66] M. Ouellet, N. Voyer, M. Auger, Conformational studies of artificial ion
channels in interaction with model membranes by 2H, 31P and 15N solid-
state NMR spectroscopy, Biophys. J. 86 (2004) 204a.
[67] X. Qiu, P.A. Mirau, C. Pidgeon, Magnetically induced orientation of
phosphatidylcholine membranes, Biochim. Biophys. Acta 1147 (1993)
59–72.
[68] J. Seelig, F. Borle, T.A. Cross, Magnetic ordering of phospholipid
membranes, Biochim. Biophys. Acta 814 (1985) 195–198.
[69] J.B. Speyer, P.K. Sripada, S.K. Das Gupta, G.G. Shipley, R.G. Griffin,
Magnetic orientation of sphingomyelin-lecithin bilayers, Biophys. J. 51
(1987) 687–691.
[70] D.L. Worcester, Structural origins of diamagnetic anisotropy in proteins,
Proc. Natl. Acad. Sci. U. S. A. 75 (1978) 5475–5477.
[71] B.B. Bonev, Y.-N. Lam, G. Anderluh, A. Watts, R.S. Norton, F. Separovic,
Effects of the eukaryotic pore-forming cytolysin equinatoxin II on lipid
membranes and the role of sphingomyelin, Biophys. J. 84 (2003)
2382–2392.
[72] D. Huster, X. Yao, K. Jakes, M. Hong, Conformational changes of colicin
Ia channel-forming domain upon membrane binding: a solid-state NMR
study, Biochim. Biophys. Acta 1561 (2002) 159–170.
[73] M.S. Balla, J.H. Bowie, F. Separovic, Solid-state NMR study of
antimicrobial peptides from Australian frogs in phospholipid membranes,
Eur. Biophys. J. 33 (2004) 109–116.
[74] U. Banerjee, R. Zidovetzki, R.R. Birge, S.I. Chan, Interaction of
alamethicin with lecithin bilayers: a 31P and 2H NMR study, Biochemistry
24 (1985) 7621–7627.
[75] P.C. Dave, E.K. Tiburu, K. Damodaran, G.A. Lorigan, Investigating
structural changes in the lipid bilayer upon insertion of the transmembrane
domain of the membrane-bound protein phospholamban utilizing 31P and
2H solid-state NMR spectroscopy, Biophys. J. 86 (2004) 1564–1573.
[76] Y. Hori, M. Demura, T. Niidome, H. Aoyagi, T. Asakura, Orientational
behavior of phospholipid membranes with mastoparan studied by 31P solid
state NMR, FEBS Lett. 455 (1999) 228–232.
[77] K.J. Hallock, K. Henzler Wildman, D.-K. Lee, A. Ramamoorthy, An
innovative procedure using a sublimable solid to align lipid bilayers for
solid-state NMR studies, Biophys. J. 82 (2002) 2499–2503.
[78] F.M. Marassi, K.J. Crowell, Hydration-optimized oriented phospholipid
bilayer samples for solid-state NMR structural studies of membrane
proteins, J. Magn. Reson. 161 (2003) 64–69.
[79] F. Moll III, T.A. Cross, Optimizing and characterizing alignment of
oriented lipid bilayers containing gramicidin D, Biophys. J. 57 (1990)
351–362.
[80] P. Balgavy, M. Dubnickova, N. Kucerka, M.A. Kiselev, S.P. Yaradaikin, D.
Uhrikova, Bilayer thickness and lipid interface area in unilamellar
extruded 1,2-diacylphosphatidylcholine liposomes: a small-angle neutron
scattering study, Biochim. Biophys. Acta 1512 (2001) 40–52.
1244 M. Ouellet et al. / Biochimica et Biophysica Acta 1758 (2006) 1235–1244[81] M.R.R. De Planque, D.V. Greathouse, R.E. Koeppe II, H. Schäfer, D.
Marsh, J.A. Killian, Influence of lipid/peptide hydrophobic mismatch on
the thickness of diacylphosphatidylcholine bilayers. A 2H NMR and ESR
study using designed transmembrane α-helical peptides and gramicidin A,
Biochemistry 37 (1998) 9333–9345.
[82] S.H. Park, S.J. Opella, Tilt angle of a trans-membrane helix is determined
by hydrophobic mismatch, J. Mol. Biol. 350 (2005) 310–318.
[83] J.H. Davis, The description of membrane lipid conformation, order
and dynamics by 2H-NMR, Biochim. Biophys. Acta 737 (1983)
117–171.
[84] J. Seelig, A. Seelig, Lipid conformation in model membrane and biological
membranes, Q. Rev. Biophys. 13 (1980) 19–61.
[85] E.J. Dufourc, I.C.P. Smith, J. Dufourcq, Molecular details of melittin-
induced lysis of phospholipid membranes as revealed by deuterium and
phosphorus NMR, Biochemistry 25 (1986) 6448–6455.[86] E.J. Dufourc, J.-M. Bonmatin, J. Dufourcq, Membrane structure and
dynamics by 2H- and 31P-NMR. Effects of amphipatic peptidic toxins
on phospholipid and biological membranes, Biochimie 71 (1989)
117–123.
[87] M.R.R. De Planque, J.-W.P. Boots, D.T.S. Rijkers, R.M.J. Liskamp, D.V.
Greathouse, J.A. Killian, The effects of hydrophobic mismatch between
phosphatidylcholine bilayers and transmembrane α-helical peptides
depend on the nature of interfacially exposed aromatic and charged
residues, Biochemistry 41 (2002) 8396–8404.
[88] K. Belohorcova, J. Qian, J.H. Davis, Molecular dynamics and 2H-NMR
study of the influence of an amphiphilic peptide on membrane order and
dynamics, Biophys. J. 79 (2000) 3201–3216.
[89] K.J. Hallock, D.K. Lee, A. Ramamoorthy, MSI-78, an analogue of the
magainin antimicrobial peptides, disrupts lipid bilayer structure via
positive curvature strain, Biophys. J. 84 (2003) 3052–3060.
